This is a non-core endpoint: only basic statistics are computed.
Sexual assault by bodily force
VWXY20_SEXUAL_ASSAU_BODILY_FORCE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
92 |
4. Check minimum number of eventsNone |
92 |
5. Include endpointsNone |
92 |
6. Filter based on genotype QC (FinnGen only) |
92 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Similar endpoints
↥List of similar endpoints to
Sexual assault by bodily force
based on the number of shared cases.
Similar with more cases:
- Assault
- External causes of morbidity and mortality
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 92 | 85 | 7 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.00 |
| Median age at first event (years) | 30.53 | 28.68 | 52.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 80
- Matched controls
- 800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T74.2
ICD-10 Finland
Sexual abuse
+∞
38.7
34
*
Y05.9
ICD-10 Finland
Sexual assault by bodily force by unknown person
+∞
35.0
31
*
Y05.0
ICD-10 Finland
Sexual assault by bodily force by spouse or partner
+∞
27.7
25
*
T74.1
ICD-10 Finland
Physical abuse
87.4
18.7
20
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
30.4
18.2
24
11
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
37.3
16.1
20
7
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
32.7
15.6
20
8
Y05.8
ICD-10 Finland
Sexual assault by bodily force by other known person
+∞
15.1
14
*
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
60.6
13.4
15
*
N05AH04
ATC
quetiapine; oral
6.9
12.8
38
93
F43.1
ICD-10 Finland
Post-traumatic stress disorder
15.1
11.6
19
16
P15
ICPC
Chronic alcohol abuse
38.2
10.7
13
*
N06AX11
ATC
mirtazapine; oral
4.7
9.4
42
153
N05BA04
ATC
oxazepam; oral
4.8
9.4
38
126
F10.20
ICD-10 Finland
Alcohol dependence currently independent
41.9
9.3
11
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
23.1
8.8
12
6
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.2
8.5
29
78
Y05.2
ICD-10 Finland
Sexual assault by bodily force by friend
+∞
8.5
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.5
8.4
27
68
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
37.6
8.3
10
*
W00
ICD-10 Finland
Fall on same level involving ice and snow
8.0
8.0
18
28
SPAT1240
SPAT
Therapeutic discussion
5.1
8.0
27
72
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.0
7.7
41
167
N06AB10
ATC
escitalopram; oral
4.2
7.6
35
126
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
12.7
7.6
13
12
N06AB04
ATC
citalopram; systemic
4.3
7.4
32
108
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.9
7.4
21
45
Y09
ICD-10 Finland
Assault by unspecified means
+∞
7.4
7
*
P29
ICPC
Psychological sympt/compl other
6.6
7.4
19
36
S18
ICPC
Laceration/cut
3.8
7.1
39
161
F10.09
ICD-10 Finland
Alcohol intoxication UNS
25.0
6.8
9
*
Z29
ICPC
Social problem NOS
16.1
6.6
10
7
X59
ICD-10 Finland
Exposure to unspecified factor
4.4
6.5
25
75
C07AA05
ATC
propranolol; systemic
4.0
6.4
28
94
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
+∞
6.3
6
*
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
+∞
6.3
6
*
N02AJ06
ATC
codeine and paracetamol; systemic
3.4
6.3
42
196
S06.0
ICD-10 Finland
Concussion
5.1
6.3
20
49
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.8
6.2
29
103
P74
ICPC
Anxiety disorder/anxiety state
8.4
6.2
13
18
N05CF01
ATC
zopiclone; oral
3.8
6.2
31
114
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.3
6.0
46
233
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.1
6.0
14
23
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011288) Drugs identified in Urine by Screen method
24
53
5.77
10.99
3.5
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
25
65
4.91
9.44
4.2
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
109
4.16
9.16
2.9
2.5
u/l
1941.4
3868.7
0.38
12
50
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
59
4.86
8.78
4.2
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
35
5.73
8.26
5.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
73
4.33
8.09
4.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
73
4.33
8.09
4.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
74
4.27
7.93
4.2
1.4
—
—
—
0
0
(3012544) pH of Venous blood
19
45
5.06
7.91
5.1
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
74
4.03
7.16
4.1
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
17
40
4.99
7.10
7.2
7.2
mmol/l
0.3
1.6
0.64
11
28
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
150
3.30
6.81
2.9
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
14
30
5.32
6.45
3.9
2.7
g/l
128.9
131.7
0.17
14
30
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
53
4.26
6.43
1.4
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
53
4.26
6.43
1.4
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
48
244
3.02
6.37
4.9
2.5
u/l
31.2
25.7
0.66
48
232
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
56
322
2.89
5.75
7.8
5.1
umol/l
8.4
10.1
1.21
56
304
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
49
263
2.85
5.73
8.1
4.9
mmol/l
1.2
1.2
1.15
43
220
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
29
5.06
5.71
1.5
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
26
5.16
5.43
1.5
1.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
8
6
14.42
5.18
16.9
12.7
nmol/l
874.4
1487.0
—
8
6
(3021879) Hepatitis B virus core Ab [Presence] in Serum
24
91
3.22
5.16
1.9
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
34
160
2.78
4.98
3.7
3.0
kg/l
1.0
1.0
—
5
24
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
24
5.07
4.92
9.8
3.4
%
53.7
45.9
0.32
11
24
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
24
5.07
4.92
1.5
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
20
5.49
4.90
1.8
4.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
36
180
2.64
4.64
2.4
2.6
ng/l
10.7
17.2
1.31
16
81
(3000991) Gas panel - Venous blood
12
33
4.03
4.07
10.1
7.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
73
3.02
3.94
2.1
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
27
127
2.59
3.85
3.7
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
74
551
2.75
3.76
5.2
2.6
u/l
78.1
31.9
1.02
74
533
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
146
2.44
3.57
4.2
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
34
187
2.30
3.41
9.1
4.7
inr
1.2
1.1
0.54
19
74
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
19
79
2.77
3.41
2.8
2.1
umol/l
8.6
5.8
0.47
14
63
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
33
3.65
3.31
1.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
88
2.63
3.22
1.5
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
216
2.19
3.19
4.2
3.5
estimate
0.0
0.0
0.00
15
98
(3003458) Phosphate [Moles/volume] in Serum or Plasma
15
57
2.95
3.15
3.2
3.9
mmol/l
1.1
1.0
0.38
15
51
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
8
7.92
3.10
7.5
4.6
umol/l
427.0
393.3
—
6
8
(3018418) pH of Serum or Plasma
30
164
2.23
3.01
2.2
3.4
ph
7.4
7.4
—
8
37
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
60
2.79
2.87
1.5
1.3
miu/ml
111.5
328.3
—
5
33
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
18
4.76
2.86
12.3
10.4
%
0.9
0.7
—
8
18
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
167
2.18
2.86
3.6
3.4
—
—
—
0
0
(4198724)
5
6
8.72
2.78
2.6
1.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
24
4.04
2.75
2.4
2.3
%
2.2
1.5
—
9
24
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
19
4.50
2.75
12.3
9.9
%
2.3
1.6
—
8
19
(3018405) Lactate [Moles/volume] in Arterial blood
6
10
6.33
2.74
3.7
3.8
mmol/l
1.4
1.5
—
6
10
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
228
2.04
2.69
4.4
2.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
36
222
2.02
2.60
6.6
4.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
11
5.75
2.58
1.3
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
18
84
2.42
2.55
2.9
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
16
4.64
2.52
8.1
2.6
mmol/l
1.7
1.2
—
7
16
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
16
4.64
2.52
1.9
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
183
2.05
2.51
4.4
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
34
3.18
2.50
10.2
4.0
mmol/l
23.8
25.1
—
10
34
(3021960) Folate [Moles/volume] in Serum or Plasma
26
144
2.12
2.48
1.8
1.5
nmol/l
17.3
19.7
0.65
26
128
(3021589) Normoblasts [#/volume] in Blood
50
352
1.92
2.42
13.1
8.1
e9/l
0.0
0.0
0.00
41
297
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
35
3.08
2.39
2.4
1.7
e6/l
0.5
0.2
—
10
35
(3013650) Neutrophils [#/volume] in Blood by Automated count
57
423
1.91
2.31
12.0
8.2
e9/l
4.0
4.1
0.05
50
379
(3014007) Fractional oxyhemoglobin in Arterial blood
7
18
4.12
2.30
13.9
10.7
%
95.2
92.8
—
7
18
(3013115) Eosinophils [#/volume] in Blood
52
376
1.88
2.27
8.3
5.2
e9/l
0.2
0.2
0.77
46
347
(3001604) Monocytes [#/volume] in Blood
50
359
1.86
2.22
8.3
5.1
e9/l
0.6
0.5
0.18
44
323
(3000494) Fungus identified in Specimen by Culture
15
69
2.40
2.19
1.5
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
50
361
1.84
2.16
8.2
5.1
e9/l
0.0
0.0
0.93
44
325
(3027273) Bicarbonate [Moles/volume] in Venous blood
8
25
3.40
2.15
5.8
2.7
mmol/l
25.2
24.6
—
8
25
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
15
4.20
2.07
1.3
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
8
26
3.27
2.07
1.7
1.7
ug/l
13.7
4.1
—
8
21
(3023511) Choriogonadotropin [Units/volume] in Urine
14
64
2.40
2.07
1.9
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
17
85
2.23
2.06
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
51
2.56
2.05
2.2
3.4
mmol/l
1.2
1.2
0.00
12
46
(3038515) Glucose [Moles/volume] in Venous blood
6
16
3.93
1.97
6.5
2.6
mmol/l
8.3
7.2
—
6
16
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
16
3.93
1.97
1.5
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
35
233
1.81
1.92
2.4
1.7
pmol/l
93.8
96.4
0.12
24
118
(3035350) Ketones [Presence] in Urine by Test strip
55
419
1.78
1.91
4.0
3.3
estimate
0.0
0.0
0.00
16
99
(3020891) Body temperature
5
12
4.34
1.85
3.4
4.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
12
4.34
1.85
1.4
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
36
245
1.77
1.82
3.9
2.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
83
2.12
1.78
2.6
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
38
265
1.74
1.76
4.7
3.2
e6/l
42.7
53.7
0.15
30
178
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
19
3.30
1.69
13.5
6.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
10
44
2.43
1.59
6.1
4.9
—
0.0
—
0
9
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
263
1.68
1.57
3.9
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
54
425
1.66
1.53
4.3
3.3
estimate
0.0
0.0
0.00
17
96
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
79
691
2.01
1.53
15.2
8.2
ml/min/173m2
100.3
95.6
1.18
69
552
(3019198) Lymphocytes [#/volume] in Blood
50
386
1.65
1.53
8.3
4.9
e9/l
2.3
1.9
1.55
45
351
(3021440) Promyelocytes/100 leukocytes in Blood
10
45
2.37
1.52
6.1
4.8
—
0.1
—
0
10
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
31
212
1.70
1.50
1.4
1.3
u/ml
3.5
1.1
0.54
12
64
(46235355) HIV 1 and 2 tests - Meaningful Use set
48
368
1.64
1.50
3.1
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
67
560
1.72
1.49
5.1
4.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
22
2.84
1.46
2.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
53
420
1.62
1.43
5.1
4.7
estimate
0.0
0.0
0.00
16
99
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
86
787
2.42
1.42
17.4
9.4
mg/l
15.3
20.6
0.83
77
585
(36304419) Bacteria [Presence] in Urine
28
189
1.69
1.42
4.4
2.5
—
—
—
0
0
(3019225) pH of Specimen
9
41
2.32
1.41
2.8
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
61
2.11
1.40
3.6
3.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
199
0.49
1.39
1.5
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
87
801
2.58
1.36
13.4
7.7
u/l
26.9
23.5
1.21
87
772
(3002179) Metamyelocytes/100 leukocytes in Blood
9
43
2.21
1.34
6.6
5.0
—
0.4
—
0
7
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
43
330
1.57
1.29
4.3
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
126
1.75
1.28
2.7
3.7
mg/mmol
6.0
25.0
1.19
14
82
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
49
388
1.56
1.28
5.2
4.1
—
—
—
0
0
(3044889) 12 lead EKG panel
51
408
1.56
1.27
3.2
2.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
50
2.12
1.21
1.5
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
92
886
+∞
1.18
27.2
14.0
pg
30.2
30.0
0.40
92
879
(3024731) MCV [Entitic volume]
92
885
+∞
1.18
27.3
14.0
fl
90.7
90.1
0.71
92
878
(1002224) Polysomnography panel
0
36
0.00
1.17
0.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
97
1.79
1.16
4.3
2.4
e6/l
9.7
5.7
0.37
11
53
(3007164) IgA [Mass/volume] in Serum or Plasma
27
190
1.60
1.15
1.3
1.3
g/l
1.9
2.0
0.19
21
132
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
16
98
1.77
1.12
4.4
2.4
e6/l
0.6
0.9
0.32
11
55
(4034850)
5
21
2.46
1.10
5.6
4.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
31
231
1.52
1.02
5.3
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
31
232
1.51
1.00
2.6
1.8
—
—
—
0
0
(3015736) pH of Urine
42
335
1.47
0.99
4.2
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
25
179
1.54
0.98
11.0
6.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
12
70
1.82
0.98
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
78
1.78
0.97
1.1
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
92
888
+∞
0.97
27.4
14.1
g/l
132.5
133.1
0.15
92
880
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
55
1.92
0.96
1.1
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
7
37
1.96
0.96
3.3
4.7
ug/l
23.8
8.8
—
7
27
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
16
103
1.67
0.95
3.8
2.6
ng/l
154.3
250.7
—
8
48
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
312
1.43
0.89
2.8
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
6
30
2.07
0.88
1.8
1.2
e9/l
56.5
79.7
—
6
23
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
44
1.89
0.88
1.5
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
65
1.79
0.87
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3013512) EKG study
19
134
1.53
0.79
4.1
2.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
34
1.82
0.78
1.8
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
34
1.82
0.78
1.5
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
271
1.40
0.77
2.0
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
23
2.24
0.77
1.4
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
118
1.54
0.76
1.9
3.0
mg/l
36.1
153.3
0.92
11
74
(3000492) Spirometry study
9
56
1.67
0.75
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
25
2.06
0.74
1.8
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
25
2.06
0.74
1.8
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
26
1.97
0.72
1.8
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
88
1.56
0.65
1.1
1.3
iu/ml
173.3
173.5
—
6
33
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
50
1.66
0.63
2.0
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
168
1.41
0.63
2.3
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
289
1.34
0.63
2.4
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.59
0.0
1.3
—
121.8
—
0
5
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(4010399)
6
35
1.76
0.59
1.7
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
35
1.76
0.59
4.5
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
152
1.40
0.58
1.5
1.3
iu/ml
22.1
18.9
—
5
46
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
96
0.60
0.55
1.5
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
40
1.53
0.52
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
22
174
1.35
0.51
1.6
1.7
mg/l
1.2
0.7
0.43
13
123
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
47
1.53
0.49
1.9
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
10
69
1.50
0.46
1.2
2.1
g/l
2.7
2.6
—
10
63
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
32
1.59
0.43
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
78
0.62
0.37
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
44
1.39
0.35
2.0
1.8
—
—
—
0
0
(4035726)
6
45
1.36
0.34
1.7
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
106
0.73
0.31
1.9
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
31
276
1.19
0.27
3.4
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
148
0.78
0.27
1.7
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
36
327
1.17
0.25
2.0
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
271
1.16
0.22
1.9
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
13
0.00
0.21
0.0
1.4
—
90.1
—
0
13
(40768804) Tissue Pathology biopsy report
35
321
1.15
0.20
1.9
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
49
1.24
0.20
8.3
4.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
57
1.25
0.19
2.7
2.3
—
19.4
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
85
0.81
0.15
1.7
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
126
0.86
0.12
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
86
1.18
0.11
1.6
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
45
1.12
0.10
1.0
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
65
1.08
0.08
2.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
85
1.07
0.07
3.8
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
31
322
0.94
0.05
2.2
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
78
771
1.08
0.03
19.1
9.9
%
37.3
39.8
1.05
58
650
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
74
731
1.06
0.03
4.0
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
20
205
0.97
0.00
5.9
4.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
141
0.99
0.00
1.5
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
59
0.84
0.00
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
416.0
—
0
6
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
179.1
—
0
5
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
10.4
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
17.5
—
0
5
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
134.0
—
0
6
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.2
—
30.6
—
0
5
(3006245) CD3-CD19+ cells/100 cells in Blood
0
6
0.00
0.00
0.0
1.7
—
4.7
—
0
6
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
49
1.02
0.00
4.4
2.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_SEXUAL_ASSAU_BODILY_FORCE – Sexual assault by bodily force
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).